美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CervoMed

3.72

-0.2000-5.10%

盘后：3.720.00000.00%16:10 EDT

成交量：5.29万

成交额：19.97万

市值：3,442.01万

市盈率：-1.25

高：4.00

开：3.90

低：3.68

收：3.92

52周最高：14.00

52周最低：3.58

股本：925.27万

流通股本：493.43万

量比：1.56

换手率：1.07%

股息：- -

股息率：- -

每股收益(TTM):-2.9824

每股收益(LYR):-2.9824

净资产收益率：-93.92%

总资产收益率：-53.62%

市净率：1.89

市盈率(LYR):-1.25

数据加载中...

总览公司新闻资讯公告

BUZZ-CervoMed 因实验性药物在早期痴呆症患者中显示出疗效而上涨

CervoMed于2026年Ad/Pd™科学会议公布新数据，进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效

CervoMed确定针对路易体痴呆症患者的三期临床试验配方及给药方案

Cervomed Inc.盘中异动股价大涨5.14%

CervoMed旗下Neflamapimod获选纳入英国Experts-ALS平台，旨在优先推进肌萎缩侧索硬化症的潜力疗法

Cervomed Inc.盘中异动下午盘股价大跌5.17%报7.15美元

CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据

Cervomed Inc.盘中异动急速下跌6.68%报7.66美元

Cervomed Inc.盘中异动早盘股价大跌5.21%报6.91美元

Cervomed Inc.盘中异动大幅上涨5.56%报7.41美元

CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致

新闻稿：CervoMed通过任命生命科学商业战略专家David Quigley强化董事会

Cervomed Inc.盘中异动急速跳水5.19%

嗡嗡声--美国股票走势-联合租赁、戴尔、Datadog

BUZZ-痴呆症药物在中期研究中显示出前景后，CervoMed 公司业绩上涨

CervoMed公布2B期临床试验新数据，显示Neflamapimod治疗路易体痴呆症的潜力

CervoMed任命Matthew Winton博士为首席商务和业务官

Cervomed Inc.盘中异动股价大涨6.36%报8.69美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CRVO/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":3.72,"timestamp":1774641600000,"preClose":3.92,"halted":0,"volume":52900,"hourTrading":{"tag":"盘后","latestPrice":3.72,"preClose":3.72,"latestTime":"16:10 EDT","volume":559,"amount":2080.230178,"timestamp":1774642204782,"change":0,"changeRate":0,"amplitude":0.008065},"delay":0,"changeRate":-0.05102040816326524,"floatShares":4934300,"shares":9252719,"eps":-2.982424,"marketStatus":"盘后交易","change":-0.2,"latestTime":"03-27 18:26:43 EDT","open":3.9,"high":4,"low":3.68,"amount":199666.3422,"amplitude":0.081633,"askPrice":4,"askSize":20,"bidPrice":3.6,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.982424,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774656000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":3.92,"postHourTrading":{"tag":"盘后","latestPrice":3.72,"preClose":3.72,"latestTime":"16:10 EDT","volume":559,"amount":2080.230178,"timestamp":1774642204782,"change":0,"changeRate":0,"amplitude":0.008065},"volumeRatio":1.564746},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","floatShares":4934300,"roa":"-53.62%","roe":"-93.92%","lyrEps":-2.982424,"volumeRatio":1.564746,"shares":9252719,"dividePrice":0,"high":4,"amplitude":0.081633,"preClose":3.92,"low":3.68,"week52Low":3.58,"pbRate":"1.89","psRate":"8.59","week52High":14,"institutionHeld":0,"latestPrice":3.72,"committee":-0.333333,"eps":-2.982424,"divideRate":0,"volume":52900,"delay":0,"ttmEps":-2.982424,"open":3.9,"prevYearClose":7.9,"prevWeekClose":4.02,"prevMonthClose":3.99,"prevQuarterClose":7.9,"fiveDayClose":4.02,"twentyDayClose":3.99,"sixtyDayClose":7.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRVO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-13","symbol":"CRVO","fiscalQuarterEnding":"2025/12","expectedEps":-0.79,"name":null,"time":"盘后","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-11-07","symbol":"CRVO","fiscalQuarterEnding":"2025/09","expectedEps":-0.68,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-08-08","symbol":"CRVO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-05-12","symbol":"CRVO","fiscalQuarterEnding":"2025/03","expectedEps":-0.6,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2025-03-17","symbol":"CRVO","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":8,"updateTime":1766116800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRVO","date":"2026-03-26","current":-1.247308,"percent":0.985938,"low":-119.682483,"twenty":-37.39506,"median":-5.035697,"eighty":-2.82005,"high":-1.31262,"avg":-19.225414,"sd":24.140611,"marketCap":37405224},"quantilePoints":[{"date":"2023-09-01","current":-5.788607,"twenty":-5.849231,"median":-5.813052,"eighty":-5.769051,"marketCap":33591560},{"date":"2023-09-08","current":-5.135433,"twenty":-5.817941,"median":-5.700604,"eighty":-4.975855,"marketCap":29801161},{"date":"2023-09-15","current":-4.791246,"twenty":-5.769051,"median":-5.182368,"eighty":-4.935961,"marketCap":27803825},{"date":"2023-09-22","current":-4.51746,"twenty":-5.708427,"median":-5.1589,"eighty":-4.822536,"marketCap":26215035},{"date":"2023-09-29","current":-4.66902,"twenty":-5.505043,"median":-5.045475,"eighty":-4.536234,"marketCap":27094543},{"date":"2023-10-06","current":-5.250814,"twenty":-5.262548,"median":-5.040586,"eighty":-4.536234,"marketCap":30470722},{"date":"2023-10-13","current":-6.893527,"twenty":-5.817941,"median":-5.065031,"eighty":-4.595684,"marketCap":40003462},{"date":"2023-10-20","current":-8.995809,"twenty":-6.690143,"median":-5.197035,"eighty":-4.691783,"marketCap":52203100},{"date":"2023-10-27","current":-9.201148,"twenty":-7.153624,"median":-5.22148,"eighty":-4.714546,"marketCap":53394692},{"date":"2023-11-03","current":-8.379791,"twenty":-8.309389,"median":-5.27037,"eighty":-4.77036,"marketCap":48628322},{"date":"2023-11-10","current":-9.709606,"twenty":-8.530373,"median":-5.764162,"eighty":-4.78929,"marketCap":56345302},{"date":"2023-11-17","current":-41.851906,"twenty":-9.287195,"median":-5.866832,"eighty":-4.791246,"marketCap":55950767},{"date":"2023-11-24","current":-43.761983,"twenty":-9.977525,"median":-6.385068,"eighty":-4.83818,"marketCap":58504301},{"date":"2023-12-01","current":-41.597229,"twenty":-22.855354,"median":-7.177091,"eighty":-4.969206,"marketCap":55610296},{"date":"2023-12-08","current":-37.39506,"twenty":-39.737313,"median":-7.68555,"eighty":-5.041564,"marketCap":49992521},{"date":"2023-12-15","current":-37.352614,"twenty":-39.16082,"median":-8.389569,"eighty":-5.054275,"marketCap":49935776},{"date":"2023-12-22","current":-28.736045,"twenty":-38.685423,"median":-8.477572,"eighty":-5.063075,"marketCap":38416500},{"date":"2023-12-29","current":-26.825968,"twenty":-38.401034,"median":-8.868694,"eighty":-5.079111,"marketCap":35862966},{"date":"2024-01-05","current":-39.899383,"twenty":-38.549596,"median":-9.044699,"eighty":-5.121353,"marketCap":53340488},{"date":"2024-01-12","current":-39.88198,"twenty":-39.488419,"median":-9.670494,"eighty":-5.172981,"marketCap":53317222},{"date":"2024-01-19","current":-38.625999,"twenty":-39.313626,"median":-10.04206,"eighty":-5.199968,"marketCap":51638132},{"date":"2024-01-26","current":-38.965567,"twenty":-39.313626,"median":-10.775414,"eighty":-5.223436,"marketCap":52092093},{"date":"2024-02-02","current":-34.593614,"twenty":-39.237223,"median":-27.727949,"eighty":-5.242992,"marketCap":46247338},{"date":"2024-02-09","current":-43.719537,"twenty":-39.237223,"median":-28.736045,"eighty":-5.262548,"marketCap":58447556},{"date":"2024-02-16","current":-68.677874,"twenty":-39.888941,"median":-31.961952,"eighty":-5.505043,"marketCap":91813733},{"date":"2024-02-23","current":-59.169936,"twenty":-40.466999,"median":-34.275268,"eighty":-5.692782,"marketCap":79102808},{"date":"2024-03-01","current":-63.372175,"twenty":-41.597229,"median":-35.401364,"eighty":-5.759273,"marketCap":84720676},{"date":"2024-03-08","current":-73.849585,"twenty":-41.945287,"median":-36.142899,"eighty":-5.808163,"marketCap":98727664},{"date":"2024-03-15","current":-76.245081,"twenty":-43.210183,"median":-36.501144,"eighty":-5.849231,"marketCap":101930142},{"date":"2024-03-22","current":-103.758666,"twenty":-50.901256,"median":-37.320992,"eighty":-6.027192,"marketCap":138712367},{"date":"2024-03-28","current":-90.558053,"twenty":-57.709789,"median":-37.373837,"eighty":-6.291199,"marketCap":121064797},{"date":"2024-04-05","current":-61.481111,"twenty":-59.566286,"median":-37.479952,"eighty":-6.48676,"marketCap":133529165},{"date":"2024-04-12","current":-71.595379,"twenty":-59.997513,"median":-38.212361,"eighty":-6.942417,"marketCap":155496070},{"date":"2024-04-19","current":-71.737433,"twenty":-62.930842,"median":-38.413768,"eighty":-7.153624,"marketCap":155804594},{"date":"2024-04-26","current":-94.969175,"twenty":-65.856384,"median":-38.647222,"eighty":-7.237715,"marketCap":206260987},{"date":"2024-05-03","current":-91.738931,"twenty":-67.584491,"median":-38.965567,"eighty":-7.396119,"marketCap":199245307},{"date":"2024-05-10","current":-90.826862,"twenty":-70.379394,"median":-39.220244,"eighty":-7.806798,"marketCap":197264409},{"date":"2024-05-17","current":-48.426621,"twenty":-71.185147,"median":-39.390029,"eighty":-8.309389,"marketCap":201061130},{"date":"2024-05-24","current":-37.632017,"twenty":-70.941929,"median":-39.252477,"eighty":-8.383702,"marketCap":156243317},{"date":"2024-05-31","current":-37.651896,"twenty":-70.600999,"median":-39.231253,"eighty":-8.399347,"marketCap":156325854},{"date":"2024-06-07","current":-38.148885,"twenty":-69.492975,"median":-39.142864,"eighty":-8.458016,"marketCap":158389289},{"date":"2024-06-14","current":-37.791053,"twenty":-68.677874,"median":-39.132924,"eighty":-8.477572,"marketCap":156903616},{"date":"2024-06-21","current":-39.600094,"twenty":-68.284435,"median":-39.132924,"eighty":-8.688778,"marketCap":164414520},{"date":"2024-06-28","current":-34.033815,"twenty":-67.93606,"median":-39.122984,"eighty":-8.944963,"marketCap":141304045},{"date":"2024-07-05","current":-30.813326,"twenty":-67.00636,"median":-39.083225,"eighty":-9.025143,"marketCap":127932985},{"date":"2024-07-12","current":-31.707906,"twenty":-66.374913,"median":-38.90211,"eighty":-9.138568,"marketCap":131647168},{"date":"2024-07-19","current":-32.304293,"twenty":-66.254136,"median":-38.668445,"eighty":-9.459288,"marketCap":134123291},{"date":"2024-07-26","current":-27.89103,"twenty":-66.009803,"median":-38.625997,"eighty":-9.678316,"marketCap":115799986},{"date":"2024-08-02","current":-21.131978,"twenty":-65.799563,"median":-38.413768,"eighty":-9.715473,"marketCap":87737266},{"date":"2024-08-09","current":-18.460659,"twenty":-64.992694,"median":-38.255401,"eighty":-10.106595,"marketCap":93102198},{"date":"2024-08-16","current":-29.88401,"twenty":-63.82037,"median":-38.148885,"eighty":-10.558342,"marketCap":150713310},{"date":"2024-08-23","current":-26.709039,"twenty":-63.123956,"median":-37.878225,"eighty":-10.740213,"marketCap":134701053},{"date":"2024-08-30","current":-30.47318,"twenty":-62.875574,"median":-37.791053,"eighty":-10.88395,"marketCap":153684657},{"date":"2024-09-06","current":-23.484969,"twenty":-62.310952,"median":-37.632017,"eighty":-13.958048,"marketCap":118441183},{"date":"2024-09-13","current":-28.656572,"twenty":-61.520597,"median":-37.39506,"eighty":-19.017097,"marketCap":144523004},{"date":"2024-09-20","current":-27.560062,"twenty":-60.889782,"median":-37.352614,"eighty":-20.363844,"marketCap":138992998},{"date":"2024-09-27","current":-24.761504,"twenty":-59.992238,"median":-37.044217,"eighty":-21.696558,"marketCap":124879101},{"date":"2024-10-04","current":-23.484969,"twenty":-59.885067,"median":-36.618159,"eighty":-21.737099,"marketCap":118441183},{"date":"2024-10-11","current":-22.093874,"twenty":-59.702244,"median":-36.256014,"eighty":-21.195966,"marketCap":111425503},{"date":"2024-10-18","current":-23.40314,"twenty":-59.499033,"median":-36.121676,"eighty":-21.422875,"marketCap":118028496},{"date":"2024-10-25","current":-22.42119,"twenty":-59.246339,"median":-35.506843,"eighty":-21.041389,"marketCap":113076251},{"date":"2024-11-01","current":-20.964631,"twenty":-58.949205,"median":-34.593614,"eighty":-21.041389,"marketCap":105730422},{"date":"2024-11-08","current":-20.522754,"twenty":-58.467774,"median":-33.995368,"eighty":-20.604583,"marketCap":103501912},{"date":"2024-11-15","current":-7.440484,"twenty":-58.205855,"median":-32.960319,"eighty":-20.319817,"marketCap":88892790},{"date":"2024-11-22","current":-6.632186,"twenty":-57.268349,"median":-31.876883,"eighty":-19.75356,"marketCap":79235913},{"date":"2024-11-29","current":-7.461209,"twenty":-55.646905,"median":-31.638328,"eighty":-10.811593,"marketCap":89140402},{"date":"2024-12-06","current":-8.228056,"twenty":-54.314096,"median":-31.509111,"eighty":-9.711562,"marketCap":98302055},{"date":"2024-12-13","current":-1.31262,"twenty":-52.81792,"median":-30.753634,"eighty":-9.005587,"marketCap":15682107},{"date":"2024-12-20","current":-1.540602,"twenty":-48.999152,"median":-30.455494,"eighty":-8.411081,"marketCap":18405842},{"date":"2024-12-27","current":-1.658046,"twenty":-48.426621,"median":-29.978384,"eighty":-8.228056,"marketCap":19808978},{"date":"2025-01-03","current":-1.609687,"twenty":-47.997222,"median":-29.785815,"eighty":-7.657262,"marketCap":19231216},{"date":"2025-01-10","current":-1.457699,"twenty":-47.144687,"median":-29.245398,"eighty":-7.393795,"marketCap":17415393},{"date":"2025-01-17","current":-1.457699,"twenty":-44.916349,"median":-28.653863,"eighty":-7.183487,"marketCap":17415393},{"date":"2025-01-24","current":-1.59587,"twenty":-43.761983,"median":-28.638191,"eighty":-7.010773,"marketCap":19066141},{"date":"2025-01-31","current":-1.561327,"twenty":-43.745005,"median":-28.566935,"eighty":-6.6764,"marketCap":18653454},{"date":"2025-02-07","current":-1.526784,"twenty":-43.24863,"median":-27.889204,"eighty":-6.348881,"marketCap":18240767},{"date":"2025-02-14","current":-1.609687,"twenty":-42.503822,"median":-27.789183,"eighty":-5.849231,"marketCap":19231216},{"date":"2025-02-21","current":-1.575144,"twenty":-42.386727,"median":-27.612716,"eighty":-5.677137,"marketCap":18818529},{"date":"2025-02-28","current":-1.54751,"twenty":-42.123561,"median":-27.159099,"eighty":-5.235169,"marketCap":18488379},{"date":"2025-03-07","current":-1.526784,"twenty":-42.013202,"median":-26.709039,"eighty":-5.079111,"marketCap":18240767},{"date":"2025-03-14","current":-4.449091,"twenty":-41.962266,"median":-26.52242,"eighty":-4.902715,"marketCap":53154092},{"date":"2025-03-21","current":-7.633919,"twenty":-41.885863,"median":-26.463551,"eighty":-4.893488,"marketCap":124361854},{"date":"2025-03-28","current":-5.06435,"twenty":-41.817949,"median":-26.005308,"eighty":-4.799924,"marketCap":82501776},{"date":"2025-04-04","current":-5.919092,"twenty":-41.665143,"median":-25.710723,"eighty":-4.841604,"marketCap":96426126},{"date":"2025-04-11","current":-4.538149,"twenty":-41.597229,"median":-25.473418,"eighty":-4.783424,"marketCap":73929597},{"date":"2025-04-17","current":-5.235298,"twenty":-41.597229,"median":-25.219748,"eighty":-4.791246,"marketCap":85286646},{"date":"2025-04-25","current":-4.61561,"twenty":-41.512337,"median":-24.761504,"eighty":-4.727795,"marketCap":75191492},{"date":"2025-05-02","current":-5.475694,"twenty":-41.298141,"median":-24.40964,"eighty":-4.781468,"marketCap":89202869},{"date":"2025-05-09","current":-4.535478,"twenty":-40.703923,"median":-23.894115,"eighty":-4.754506,"marketCap":73886084},{"date":"2025-05-16","current":-4.092569,"twenty":-40.111614,"median":-23.509518,"eighty":-4.701084,"marketCap":76409872},{"date":"2025-05-23","current":-3.924764,"twenty":-39.899383,"median":-23.40314,"eighty":-4.546794,"marketCap":73276893},{"date":"2025-05-30","current":-3.631106,"twenty":-39.899383,"median":-22.993995,"eighty":-4.534221,"marketCap":67794181},{"date":"2025-06-06","current":-3.514575,"twenty":-39.885461,"median":-22.735979,"eighty":-4.503786,"marketCap":65618501},{"date":"2025-06-13","current":-3.551865,"twenty":-39.7837,"median":-22.503019,"eighty":-4.258784,"marketCap":66314718},{"date":"2025-06-20","current":-3.258207,"twenty":-39.75913,"median":-22.404825,"eighty":-4.158521,"marketCap":60832005},{"date":"2025-06-27","current":-3.311811,"twenty":-39.663708,"median":-22.077508,"eighty":-4.077653,"marketCap":61832818},{"date":"2025-07-03","current":-2.633601,"twenty":-39.550025,"median":-21.823837,"eighty":-3.980044,"marketCap":49170362},{"date":"2025-07-11","current":-3.360754,"twenty":-39.440965,"median":-21.455606,"eighty":-3.896797,"marketCap":62746603},{"date":"2025-07-18","current":-3.528559,"twenty":-39.386585,"median":-21.072854,"eighty":-3.646022,"marketCap":65879582},{"date":"2025-07-25","current":-3.752298,"twenty":-39.349611,"median":-20.964631,"eighty":-3.646022,"marketCap":70056887},{"date":"2025-08-01","current":-3.845523,"twenty":-39.3019,"median":-20.547303,"eighty":-3.685176,"marketCap":71797431},{"date":"2025-08-08","current":-4.353598,"twenty":-39.293948,"median":-20.408193,"eighty":-3.727127,"marketCap":81283395},{"date":"2025-08-15","current":-4.169718,"twenty":-39.274289,"median":-19.933584,"eighty":-3.76778,"marketCap":94285206},{"date":"2025-08-22","current":-3.772796,"twenty":-39.254519,"median":-19.688096,"eighty":-3.760497,"marketCap":85310069},{"date":"2025-08-29","current":-3.813716,"twenty":-39.233455,"median":-10.865861,"eighty":-3.760497,"marketCap":86235341},{"date":"2025-09-05","current":-4.177901,"twenty":-39.220244,"median":-10.526074,"eighty":-3.773614,"marketCap":94470260},{"date":"2025-09-12","current":-3.764612,"twenty":-39.204768,"median":-9.709606,"eighty":-3.773614,"marketCap":85125014},{"date":"2025-09-19","current":-3.314496,"twenty":-39.138888,"median":-9.122923,"eighty":-3.737606,"marketCap":74947023},{"date":"2025-09-26","current":-3.199921,"twenty":-39.116968,"median":-8.741579,"eighty":-3.623336,"marketCap":72356262},{"date":"2025-10-03","current":-3.34314,"twenty":-39.09097,"median":-8.428681,"eighty":-3.551865,"marketCap":75594714},{"date":"2025-10-10","current":-3.494542,"twenty":-39.075273,"median":-8.291789,"eighty":-3.534152,"marketCap":79018220},{"date":"2025-10-17","current":-3.109897,"twenty":-39.027886,"median":-7.962078,"eighty":-3.498549,"marketCap":70320664},{"date":"2025-10-24","current":-2.897115,"twenty":-38.940184,"median":-7.633919,"eighty":-3.482878,"marketCap":65509250},{"date":"2025-10-31","current":-2.909391,"twenty":-38.804612,"median":-7.450846,"eighty":-3.374238,"marketCap":65786832},{"date":"2025-11-07","current":-2.983046,"twenty":-38.663931,"median":-7.254628,"eighty":-3.361323,"marketCap":67452321},{"date":"2025-11-14","current":-2.621936,"twenty":-38.6419,"median":-7.20399,"eighty":-3.333221,"marketCap":67082212},{"date":"2025-11-21","current":-3.258434,"twenty":-38.625998,"median":-7.137979,"eighty":-3.315314,"marketCap":83366998},{"date":"2025-11-28","current":-3.594765,"twenty":-38.625995,"median":-6.963795,"eighty":-3.314496,"marketCap":91972026},{"date":"2025-12-05","current":-3.276516,"twenty":-38.456214,"median":-6.708179,"eighty":-3.314142,"marketCap":83829634},{"date":"2025-12-12","current":-2.961884,"twenty":-38.413768,"median":-6.632186,"eighty":-3.290836,"marketCap":75779768},{"date":"2025-12-19","current":-2.857006,"twenty":-38.350099,"median":-6.354912,"eighty":-3.258434,"marketCap":73096480},{"date":"2025-12-26","current":-3.066761,"twenty":-38.300453,"median":-6.221623,"eighty":-3.198527,"marketCap":78463057},{"date":"2026-01-02","current":-2.857006,"twenty":-38.248873,"median":-6.028218,"eighty":-3.184173,"marketCap":73096480},{"date":"2026-01-09","current":-2.846157,"twenty":-38.210281,"median":-5.866832,"eighty":-3.139814,"marketCap":72818898},{"date":"2026-01-16","current":-2.560456,"twenty":-38.170115,"median":-5.764162,"eighty":-3.103963,"marketCap":65509250},{"date":"2026-01-23","current":-2.379633,"twenty":-38.109126,"median":-5.691463,"eighty":-3.066761,"marketCap":60882891},{"date":"2026-01-30","current":-1.869712,"twenty":-37.999948,"median":-5.513005,"eighty":-3.019747,"marketCap":47836557},{"date":"2026-02-06","current":-1.663573,"twenty":-37.887707,"median":-5.323443,"eighty":-2.9876,"marketCap":42562507},{"date":"2026-02-13","current":-1.638258,"twenty":-37.814908,"median":-5.250814,"eighty":-2.957395,"marketCap":41914817},{"date":"2026-02-20","current":-1.89141,"twenty":-37.791053,"median":-5.231258,"eighty":-2.930623,"marketCap":48391720},{"date":"2026-02-27","current":-1.591244,"twenty":-37.763222,"median":-5.212816,"eighty":-2.89957,"marketCap":40711963},{"date":"2026-03-06","current":-1.450202,"twenty":-37.64792,"median":-5.171192,"eighty":-2.886661,"marketCap":37103403},{"date":"2026-03-13","current":-1.565929,"twenty":-37.601604,"median":-5.067362,"eighty":-2.872563,"marketCap":40064273},{"date":"2026-03-20","current":-1.452342,"twenty":-37.462974,"median":-5.060142,"eighty":-2.848327,"marketCap":39164381},{"date":"2026-03-26","current":-1.387107,"twenty":-37.39506,"median":-5.035697,"eighty":-2.82005,"marketCap":37405224}],"updateTime":1774649313087},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRVO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620263228","title":"BUZZ-CervoMed 因实验性药物在早期痴呆症患者中显示出疗效而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2620263228","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620263228?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 20:46","pubTimestamp":1773924375,"startTime":"0","endTime":"0","summary":"BUZZ-CervoMed 因实验性药物在早期痴呆症患者中显示出疗效而上涨3月19日 - ** 生物技术公司CervoMed CRVO.O股价上涨8%至4.58美元** 该公司称，新的试验分析表明，其试验性药物neflamapimod对早期路易体痴呆症患者的疗效最佳，路易体痴呆症是一种影响记忆、思维和运动的脑部疾病 。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nL4S4071F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1190106082","title":"CervoMed于2026年Ad/Pd™科学会议公布新数据，进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190106082","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190106082?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 19:33","pubTimestamp":1773920016,"startTime":"0","endTime":"0","summary":"CervoMed在2026年Ad/Pd™科学会议上公布了最新研究数据，这些数据强化了Neflamapimod药物对不伴有阿尔茨海默病共病理的路易体痴呆患者的治疗效果。新发现突显该疗法在特定患者群体中的显著优势，为精准医疗提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"1186895438","title":"CervoMed确定针对路易体痴呆症患者的三期临床试验配方及给药方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186895438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186895438?lang=zh_cn&edition=fundamental","pubTime":"2026-03-04 20:32","pubTimestamp":1772627574,"startTime":"0","endTime":"0","summary":"CervoMed已正式确定其针对路易体痴呆症患者的三期临床试验的最终配方及给药方案。这一关键决策标志着该公司在推进神经退行性疾病治疗研究方面迈出了重要一步，为后续临床试验的开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2616287587","title":"Cervomed Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616287587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616287587?lang=zh_cn&edition=fundamental","pubTime":"2026-03-04 03:07","pubTimestamp":1772564827,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时07分，Cervomed Inc.股票出现异动，股价快速上涨5.14%。截至发稿，该股报4.09美元/股，成交量5.2395万股，换手率0.57%，振幅7.67%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为1.90%。其相关个股中，Edesa Biotech, Inc.、Onconetix, Inc.、Calcimedica, Inc.涨幅较大，Edesa Biotech, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃，换手率分别为296.56%、138.89%、128.97%，振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为76.32%、47.36%、43.99%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"1173716197","title":"CervoMed旗下Neflamapimod获选纳入英国Experts-ALS平台，旨在优先推进肌萎缩侧索硬化症的潜力疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1173716197","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173716197?lang=zh_cn&edition=fundamental","pubTime":"2026-02-18 19:02","pubTimestamp":1771412559,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，其研发的候选药物Neflamapimod已被遴选加入英国Experts-ALS平台。该平台的核心目标在于识别并优先推进针对肌萎缩侧索硬化症（ALS）最具前景的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2603621395","title":"Cervomed Inc.盘中异动 下午盘股价大跌5.17%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603621395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603621395?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 04:08","pubTimestamp":1768421338,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日04时08分，Cervomed Inc.股票出现波动，股价大幅下跌5.17%。截至发稿，该股报7.15美元/股，成交量4.623万股，换手率0.50%，振幅3.51%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115040859a4c46e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115040859a4c46e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1126237005","title":"CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1126237005","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126237005?lang=zh_cn&edition=fundamental","pubTime":"2025-11-24 20:02","pubTimestamp":1763985767,"startTime":"0","endTime":"0","summary":"CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2584917508","title":"Cervomed Inc.盘中异动 急速下跌6.68%报7.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584917508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584917508?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 22:31","pubTimestamp":1763476294,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时31分，Cervomed Inc.股票出现异动，股价大幅跳水6.68%。截至发稿，该股报7.66美元/股，成交量6829股，换手率0.07%，振幅2.07%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Clearmind Medicine Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为941.48%、452.82%、265.25%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为27.23%、16.40%、14.20%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223135950c6452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223135950c6452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2581783100","title":"Cervomed Inc.盘中异动 早盘股价大跌5.21%报6.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581783100?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 00:16","pubTimestamp":1762532193,"startTime":"0","endTime":"0","summary":"北京时间2025年11月08日00时16分，Cervomed Inc.股票出现波动，股价快速下跌5.21%。截至发稿，该股报6.91美元/股，成交量1.6724万股，换手率0.18%，振幅4.73%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Puma Biotechnology Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Metavia Inc.、Tharimmune, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为157.35%、71.84%、28.33%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为70.00%、37.11%、33.73%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108001634a6e92dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108001634a6e92dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2581740156","title":"Cervomed Inc.盘中异动 大幅上涨5.56%报7.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581740156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581740156?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 22:56","pubTimestamp":1762268171,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时56分，Cervomed Inc.股票出现异动，股价大幅上涨5.56%。截至发稿，该股报7.41美元/股，成交量2.6815万股，换手率0.29%，振幅4.20%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Abpro Holdings, Inc、Biomx Inc.较为活跃，换手率分别为278.07%、97.30%、67.72%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Nuvation Bio Inc.，振幅分别为36.13%、23.09%、22.63%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511042256119753ab53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511042256119753ab53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1166172288","title":"CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1166172288","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166172288?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 20:03","pubTimestamp":1762257793,"startTime":"0","endTime":"0","summary":"CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1180758735","title":"新闻稿：CervoMed通过任命生命科学商业战略专家David Quigley强化董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1180758735","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180758735?lang=zh_cn&edition=fundamental","pubTime":"2025-10-28 20:05","pubTimestamp":1761653141,"startTime":"0","endTime":"0","summary":"David Quigley先生最近担任麦肯锡公司的私人资本业务领导，并曾在该公司领导多个生命科学实践团队。此次任命为CervoMed在准备第三阶段临床试验和商业化计划时增添了丰富的商业战略、交易和商业专业知识。波士顿，2025年10月28日——CervoMed Inc.是一家正在开发与年龄相关的脑部疾病治疗方案的临床阶段生物技术公司，今天宣布David Quigley被任命为其董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","DLB","LU0205193047.USD","CRVO","LU0240877869.USD","LU0345774391.USD","LU0345774631.USD","BK4139","LU0240878834.USD","LU0348723411.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"2577383770","title":"Cervomed Inc.盘中异动 急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577383770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577383770?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 01:22","pubTimestamp":1761067337,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日01时22分，Cervomed Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.12美元/股，成交量5.0418万股，换手率0.54%，振幅4.32%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Minerva Neurosciences, Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为2139.14%、273.87%、197.89%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为215.34%、100.00%、67.96%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022012217a46cc1ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022012217a46cc1ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2573927059","title":"嗡嗡声--美国股票走势-联合租赁、戴尔、Datadog","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927059","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573927059?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 23:43","pubTimestamp":1759938189,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI上涨0.30%，报46,740.90点。标准普尔500指数.SPX上涨0.52%，报6749.45点；纳斯达克综合指数.IXIC上涨0.77%，报22964.05点。nL3N3VP0QB ** Elf Beauty Inc < ELF.N  >:BUZZ - 因摩根士丹利以 Rhode 护肤品业绩为由上调 PT 值而上涨   nL6N3VP0MZ ** Equifa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nL3T3VP0ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOTH","HL","LU0154245673.USD","LU0053671581.USD","CFLT","CVS","LU1242518857.USD","IE0002270589.USD","BK4123","FRPT","LU0788108826.HKD","LU2498475776.HKD","NEXT","CDE","CAT","JEF","LU0122376428.USD","LYV","SCCO","LU2211817866.USD","ARCB","EFX","LU0300736492.USD","DDOG","LU0498741890.SGD","FDX","DELL","F","LU0433182093.SGD","NEM","URI","ELF","SMTC","CMI","CTVA","CRVO","WERN","SLB","ZBIO","LU0310800965.SGD","PSX","HOWL","BLD"],"gpt_icon":1},{"id":"2573285779","title":"BUZZ-痴呆症药物在中期研究中显示出前景后，CervoMed 公司业绩上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2573285779","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573285779?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 19:55","pubTimestamp":1759924558,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nL3T3VP0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"1172856980","title":"CervoMed公布2B期临床试验新数据，显示Neflamapimod治疗路易体痴呆症的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1172856980","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172856980?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 19:00","pubTimestamp":1759921226,"startTime":"0","endTime":"0","summary":"CervoMed公布2B期临床试验新数据，显示Neflamapimod治疗路易体痴呆症的潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1136915279","title":"CervoMed任命Matthew Winton博士为首席商务和业务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1136915279","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136915279?lang=zh_cn&edition=fundamental","pubTime":"2025-10-07 20:05","pubTimestamp":1759838740,"startTime":"0","endTime":"0","summary":"波士顿，2025年10月7日 —— CervoMed Inc.是一家专注于开发年龄相关神经系统疾病治疗方法的临床阶段公司，今日宣布任命Matthew Winton博士为首席商务和业务官。Winton博士拥有近二十年的全球生物技术行业经验，在领导组织实现科学突破、发展创新和市场转型方面表现卓越。CervoMed首席执行官John Alam医学博士表示：\"很高兴欢迎Matthew这位经验丰富且经过验证的领导者和组织建设者。这一任命正值CervoMed进入后期第三阶段开发的关键时刻。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4555","LU0205194284.USD","BK4097","BK4217","BK4139","03160","LU0348723411.USD","BK4604","LU0345774391.USD","BK4099","DLB","LU0240878834.USD","LU0240877869.USD","LU0345774631.USD","LU0205193047.USD","BK4585","SMA","CRVO","TM"],"gpt_icon":0},{"id":"2572570436","title":"Cervomed Inc.盘中异动 股价大涨6.36%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572570436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572570436?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 21:51","pubTimestamp":1759499472,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时51分，Cervomed Inc.股票出现异动，股价大幅拉升6.36%。截至发稿，该股报8.69美元/股，成交量2.1024万股，换手率0.24%，振幅4.32%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Alto Neuroscience, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Palisade Bio, Inc.、Ovid Therapeutics Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为55.71%、48.44%、43.69%，振幅较大的相关个股有Alto Neuroscience, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Neurogene Inc.，振幅分别为32.88%、23.50%、17.59%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003215112a6ac30ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003215112a6ac30ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}